Lallemand Bio-Ingredients president and general manager Lars Asferg unravels the potential in the company’s recent acquisition of Swiss biotechnology firm Evolva. Asferg discusses how Evolva’s precision fermentation tech could boost Lallemand’s health and flavor and fragrance businesses. He also outlines the business unit’s key focuses for 2024.
Upcoming webinars

Introducing LifeChews® and the Next Generation of Plant-based Supplements
Sirio
Register now

Why ARA & DHA matter: Key lipids shaping infant development
dsm-firmenich
Register now

Where Structure Drives Beauty: From Scalp Health to Skin Radiance
Monteloeder
Register now
All upcoming webinars
Subscribe to our newsletters
By continuing to browse our site you agree to our Privacy Statement















